Biodexa Pharmaceuticals (LON:MTPH) Stock Price Crosses Above 50-Day Moving Average of $18.00

Biodexa Pharmaceuticals Plc (LON:MTPHGet Free Report) shares passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 18 ($0.23) and traded as high as GBX 20 ($0.25). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.23), with a volume of 73,672 shares changing hands.

Biodexa Pharmaceuticals Stock Performance

The company has a current ratio of 5.28, a quick ratio of 5.28 and a debt-to-equity ratio of 9.52. The firm has a market capitalization of £31.20 million, a price-to-earnings ratio of -21.95 and a beta of 1.22. The stock’s 50 day moving average price is GBX 18 and its two-hundred day moving average price is GBX 18.

About Biodexa Pharmaceuticals

(Get Free Report)

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection.

See Also

Receive News & Ratings for Biodexa Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biodexa Pharmaceuticals and related companies with's FREE daily email newsletter.